Immunomodulation in asthma: A distant dream or a close reality?

Arpita Bharadwaj, Devendra K. Agrawal

Research output: Contribution to journalShort survey

15 Citations (Scopus)

Abstract

The search for new treatments of asthma or any other disease for that matter is an infinite exercise. The scope for discovering new forms of treatment has increased now more than ever due to a better understanding of the molecular pathogenesis of the disease. Regulation of biomolecular or immunological events could occur at numerous points in the disease pathogenesis. This review describes the strategies to regulate the inappropriate immune responses that are elicited after exposure to an allergen. One such successful therapy is treatment with omalizumab, the anti-IgE antibody. Other therapies include cytokine antagonists, transcription factor antagonists, immunostimulatory DNA therapy, cytokine therapy and anti-T cell strategies. All these agents have been shown to be promising and could serve as an alternative approach to the treatment of asthma and maybe other allergic diseases.

Original languageEnglish
Pages (from-to)495-511
Number of pages17
JournalInternational Immunopharmacology
Volume4
Issue number4
DOIs
StatePublished - Apr 2004

Fingerprint

Immunomodulation
Asthma
Therapeutics
Cytokines
Genetic Therapy
Allergens
Transcription Factors
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Immunology
  • Pharmacology

Cite this

Immunomodulation in asthma : A distant dream or a close reality? / Bharadwaj, Arpita; Agrawal, Devendra K.

In: International Immunopharmacology, Vol. 4, No. 4, 04.2004, p. 495-511.

Research output: Contribution to journalShort survey

@article{95fedaea2899453f8250b31c6bdf2f5f,
title = "Immunomodulation in asthma: A distant dream or a close reality?",
abstract = "The search for new treatments of asthma or any other disease for that matter is an infinite exercise. The scope for discovering new forms of treatment has increased now more than ever due to a better understanding of the molecular pathogenesis of the disease. Regulation of biomolecular or immunological events could occur at numerous points in the disease pathogenesis. This review describes the strategies to regulate the inappropriate immune responses that are elicited after exposure to an allergen. One such successful therapy is treatment with omalizumab, the anti-IgE antibody. Other therapies include cytokine antagonists, transcription factor antagonists, immunostimulatory DNA therapy, cytokine therapy and anti-T cell strategies. All these agents have been shown to be promising and could serve as an alternative approach to the treatment of asthma and maybe other allergic diseases.",
author = "Arpita Bharadwaj and Agrawal, {Devendra K.}",
year = "2004",
month = "4",
doi = "10.1016/j.intimp.2004.02.001",
language = "English",
volume = "4",
pages = "495--511",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Immunomodulation in asthma

T2 - A distant dream or a close reality?

AU - Bharadwaj, Arpita

AU - Agrawal, Devendra K.

PY - 2004/4

Y1 - 2004/4

N2 - The search for new treatments of asthma or any other disease for that matter is an infinite exercise. The scope for discovering new forms of treatment has increased now more than ever due to a better understanding of the molecular pathogenesis of the disease. Regulation of biomolecular or immunological events could occur at numerous points in the disease pathogenesis. This review describes the strategies to regulate the inappropriate immune responses that are elicited after exposure to an allergen. One such successful therapy is treatment with omalizumab, the anti-IgE antibody. Other therapies include cytokine antagonists, transcription factor antagonists, immunostimulatory DNA therapy, cytokine therapy and anti-T cell strategies. All these agents have been shown to be promising and could serve as an alternative approach to the treatment of asthma and maybe other allergic diseases.

AB - The search for new treatments of asthma or any other disease for that matter is an infinite exercise. The scope for discovering new forms of treatment has increased now more than ever due to a better understanding of the molecular pathogenesis of the disease. Regulation of biomolecular or immunological events could occur at numerous points in the disease pathogenesis. This review describes the strategies to regulate the inappropriate immune responses that are elicited after exposure to an allergen. One such successful therapy is treatment with omalizumab, the anti-IgE antibody. Other therapies include cytokine antagonists, transcription factor antagonists, immunostimulatory DNA therapy, cytokine therapy and anti-T cell strategies. All these agents have been shown to be promising and could serve as an alternative approach to the treatment of asthma and maybe other allergic diseases.

UR - http://www.scopus.com/inward/record.url?scp=4444241839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444241839&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2004.02.001

DO - 10.1016/j.intimp.2004.02.001

M3 - Short survey

C2 - 15099527

AN - SCOPUS:4444241839

VL - 4

SP - 495

EP - 511

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 4

ER -